SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-21-003494
Filing Date
2021-11-08
Accepted
2021-11-08 16:51:30
Documents
14
Period of Report
2021-11-08
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K dawn-20211108.htm   iXBRL 8-K 55858
2 EX-99.1 dawn-ex99_1.htm EX-99.1 102135
3 GRAPHIC img109617361_0.jpg GRAPHIC 20511
  Complete submission text file 0000950170-21-003494.txt   318481

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT dawn-20211108_pre.xml EX-101.PRE 10289
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT dawn-20211108_lab.xml EX-101.LAB 14010
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT dawn-20211108.xsd EX-101.SCH 2490
7 EXTRACTED XBRL INSTANCE DOCUMENT dawn-20211108_htm.xml XML 4955
Mailing Address 395 OYSTER POINT BLVD STE 217 SOUTH SAN FRANCISCO CA 94080-1930
Business Address 395 OYSTER POINT BLVD STE 217 SOUTH SAN FRANCISCO CA 94080-1930 206-913-4300
Day One Biopharmaceuticals, Inc. (Filer) CIK: 0001845337 (see all company filings)

IRS No.: 832415215 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40431 | Film No.: 211388668
SIC: 2834 Pharmaceutical Preparations